Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bone marrow transplantation [Bone Marrow Transplant] NLMUID: 8702459"" wg kryterium: JN

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 368
Tytuł:
Reply to 'allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome'.
Autorzy:
Schroeder T; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany.
Fenk R; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany.
Haas R; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany.
Germing U; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany.
Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Nov; Vol. 50 (11), pp. 1483-5. Date of Electronic Publication: 2015 Aug 03.
Typ publikacji:
Letter; Comment
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma/*therapy
Myelodysplastic Syndromes/*therapy
Female ; Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Impact of novel agents followed by autologous hematopoietic stem cell transplantation for multiple myeloma patients aged 65 years or older: a retrospective single Institutional analysis.
Autorzy:
Minoia C; Haematology Unit and BMT, 'San Giuseppe Moscati' Hospital, Taranto, Italy.
Pisapia G; Haematology Unit and BMT, 'San Giuseppe Moscati' Hospital, Taranto, Italy.
Palazzo G; Haematology Unit and BMT, 'San Giuseppe Moscati' Hospital, Taranto, Italy.
Ingrosso C; Haematology Unit and BMT, 'San Giuseppe Moscati' Hospital, Taranto, Italy.
Buonanno M; Haematology Unit and BMT, 'San Giuseppe Moscati' Hospital, Taranto, Italy.
Spinosa C; Haematology Unit and BMT, 'San Giuseppe Moscati' Hospital, Taranto, Italy.
Prudenzano A; Haematology Unit and BMT, 'San Giuseppe Moscati' Hospital, Taranto, Italy.
Pricolo G; Haematology Unit and BMT, 'San Giuseppe Moscati' Hospital, Taranto, Italy.
Mazza P; Haematology Unit and BMT, 'San Giuseppe Moscati' Hospital, Taranto, Italy.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Nov; Vol. 50 (11), pp. 1486. Date of Electronic Publication: 2015 Aug 17.
Typ publikacji:
Evaluation Study; Letter
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Angiogenesis Inhibitors/*therapeutic use
Antineoplastic Agents/*therapeutic use
Bortezomib/*therapeutic use
Multiple Myeloma/*therapy
Proteasome Inhibitors/*therapeutic use
Thalidomide/*therapeutic use
Aged ; Angiogenesis Inhibitors/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bortezomib/administration & dosage ; Cyclophosphamide/pharmacology ; Female ; Filgrastim ; Granulocyte Colony-Stimulating Factor/pharmacology ; Hematopoietic Stem Cell Mobilization ; Humans ; Interferon-alpha/administration & dosage ; Male ; Multiple Myeloma/drug therapy ; Polyethylene Glycols ; Proteasome Inhibitors/administration & dosage ; Recombinant Proteins/pharmacology ; Remission Induction ; Retrospective Studies ; Thalidomide/administration & dosage ; Transplantation Conditioning ; Transplantation, Autologous ; Treatment Outcome
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents.
Autorzy:
Cook G; Department of Haematology, Transplant Immunology Group, University of Leeds, Section of Experimental Haematology, Leeds Institute of Cancer & Pathology, Leeds, UK.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Oct; Vol. 50 (10), pp. 1269-70. Date of Electronic Publication: 2015 Aug 03.
Typ publikacji:
Editorial
MeSH Terms:
Hematopoietic Stem Cell Transplantation/*methods
Multiple Myeloma/*therapy
Transplantation Conditioning/*methods
Transplantation, Autologous/*methods
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma.
Autorzy:
Rosko A; Division of Hematology, Ohio State University, Columbus, OH, USA.
Hofmeister C; Division of Hematology, Ohio State University, Columbus, OH, USA.
Benson D; Division of Hematology, Ohio State University, Columbus, OH, USA.
Efebera Y; Division of Hematology, Ohio State University, Columbus, OH, USA.
Huang Y; Division of Hematology, Ohio State University, Columbus, OH, USA.
Gillahan J; Department of Molecular Genetics, Ohio State University, Columbus, OH, USA.; Department of Molecular and Cellular Biochemistry, Ohio State University, Columbus, OH, USA.
Byrd JC; Division of Hematology, Ohio State University, Columbus, OH, USA.; Division of Medicinal Chemistry, College of Pharmacy, Ohio State University, Columbus, OH, USA.
Burd CE; Department of Molecular Genetics, Ohio State University, Columbus, OH, USA.; Department of Molecular and Cellular Biochemistry, Ohio State University, Columbus, OH, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Oct; Vol. 50 (10), pp. 1379-81. Date of Electronic Publication: 2015 Jun 29.
Typ publikacji:
Letter; Research Support, N.I.H., Extramural
MeSH Terms:
Hematopoietic Stem Cell Transplantation/*methods
Multiple Myeloma/*therapy
T-Lymphocytes/*metabolism
Transplantation Conditioning/*methods
Humans ; Multiple Myeloma/immunology ; Transplantation, Autologous
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Consolidation and maintenance therapy for multiple myeloma after autologous transplantation: where do we stand?
Autorzy:
Mohty M; 1] Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, APHP, Paris, France [2] Universite Pierre et Marie Curie, Paris, France [3] INSERM, UMRs 938, Paris, France.
Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Boston, MA, USA.
McCarthy PL; Blood and Marrow Transplant Program, Roswell Park Cancer Institute, Buffalo, NY, USA.
Attal M; Hématologie Clinique, Hôpital Purpan, and Institut Universitaire du Cancer de Toulouse (IUCT), Toulouse, France.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Aug; Vol. 50 (8), pp. 1024-9. Date of Electronic Publication: 2015 Apr 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Stem Cell Transplantation*
Consolidation Chemotherapy/*methods
Maintenance Chemotherapy/*methods
Multiple Myeloma/*therapy
Autografts ; Disease-Free Survival ; Humans ; Multiple Myeloma/mortality ; Multiple Myeloma/pathology ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma.
Autorzy:
Wildes TM; Department of Medicine, Division of Medical Oncology, Washington University School of Medicine, St Louis, MO, USA.
Finney JD; Rush University Medical College, Chicago, IL, USA.
Fiala M; Department of Medicine, Division of Medical Oncology, Washington University School of Medicine, St Louis, MO, USA.
Gao F; Division of Biostatistics, Washington University School of Medicine, St Louis, MO, USA.
Vij R; Department of Medicine, Division of Medical Oncology, Washington University School of Medicine, St Louis, MO, USA.
Stockerl-Goldstein K; Department of Medicine, Division of Medical Oncology, Washington University School of Medicine, St Louis, MO, USA.
Carson KR; Department of Medicine, Division of Medical Oncology, Washington University School of Medicine, St Louis, MO, USA.
Mikhael J; Mayo Clinic, Scottsdale, AZ, USA.
Colditz G; Department of Surgery, Washington University School of Medicine, St Louis, MO, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Aug; Vol. 50 (8), pp. 1075-82. Date of Electronic Publication: 2015 May 11.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Stem Cell Transplantation*
Multiple Myeloma/*mortality
Multiple Myeloma/*therapy
Aged ; Autografts ; Disease-Free Survival ; Female ; Humans ; Male ; Proportional Hazards Models ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma.
Autorzy:
Graff TM; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Singavi AK; Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Schmidt W; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Eastwood D; Department of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA.
Drobyski WR; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Horowitz M; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Palmer J; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.
Pasquini M; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Rizzo DJ; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Saber W; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Hari P; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Fenske TS; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Jul; Vol. 50 (7), pp. 947-53. Date of Electronic Publication: 2015 Apr 13.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma/*surgery
Multiple Myeloma/*surgery
Transplantation Conditioning/*methods
Transplantation, Autologous/*methods
Adult ; Aged ; Cohort Studies ; Female ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Lymphoma/therapy ; Male ; Middle Aged ; Multiple Myeloma/therapy ; Outpatients ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIs.
Autorzy:
Franssen LE; 1] Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands [2] Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
van de Donk NW; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
Emmelot ME; 1] Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands [2] Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Roeven MW; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Schaap N; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Dolstra H; Department of Laboratory Medicine-Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Hobo W; Department of Laboratory Medicine-Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Lokhorst HM; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
Mutis T; 1] Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands [2] Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Jun; Vol. 50 (6), pp. 822-8. Date of Electronic Publication: 2015 Mar 23.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiple Myeloma*/immunology
Multiple Myeloma*/therapy
Stem Cell Transplantation*
Graft vs Tumor Effect/*immunology
Myeloid Cells/*immunology
T-Lymphocytes, Regulatory/*immunology
Adult ; Aged ; Allografts ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma.
Autorzy:
Sahebi F; 1] City of Hope, Duarte, CA, USA [2] Southern California Kaiser Permanente, Los Angeles, CA, USA.
Iacobelli S; Università Tor Vergata, Roma, Italy.
Biezen AV; EBMT, University Medical Center, Leiden, Netherlands.
Volin L; Helsinki University Central Hospital, Helsinki, Finland.
Dreger P; University Hospital, Heidelberg, Germany.
Michallet M; Hôpital E. Herriot, Lyon, France.
Ljungman PT; Karolinska University Hospital Huddinge, Stockholm, Sweden.
de Witte T; Radboud University Medical Centre, Nijmegen, Netherlands.
Henseler A; EBMT, University Medical Center, Leiden, Netherlands.
Schaap NP; Radboud University Medical Centre, Nijmegen, Netherlands.
López-Corral L; Hospital Universitario, Salamanca, Spain.
Poire X; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Passweg J; University Hospital, Basel, Switzerland.
Hamljadi RM; Centre Pierre et Marie Curie, Alger, Algeria.
Thomas SH; City of Hope, Duarte, CA, USA.
Schonland S; University Hospital Heidelberg, Heidelberg, Germany.
Gahrton G; Karolinska University Hospital Huddinge, Stockholm, Sweden.
Morris C; Queens University of Belfast, Belfast, Northern Ireland.
KrÖger N; University Medical Center, Hamburg, Germany.
Garderet L; Hôpital Saint Antoine, Paris, France.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Jun; Vol. 50 (6), pp. 802-7. Date of Electronic Publication: 2015 Mar 23.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma/*mortality
Multiple Myeloma/*therapy
Adult ; Aged ; Allografts ; Autografts ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
G-CSF plus preemptive plerixafor vs hyperfractionated CY plus G-CSF for autologous stem cell mobilization in multiple myeloma: effectiveness, safety and cost analysis.
Autorzy:
Antar A; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Otrock ZK; Department of Pathology and Immunology, Washington University, Barnes-Jewish Hospital, St Louis, MO, USA.
Kharfan-Dabaja MA; Department of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Ghaddara HA; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Kreidieh N; Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Mahfouz R; Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Bazarbachi A; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Jun; Vol. 50 (6), pp. 813-7. Date of Electronic Publication: 2015 Mar 09.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Granulocyte Colony-Stimulating Factor/*economics
Hematopoietic Stem Cell Mobilization/*economics
Hematopoietic Stem Cell Transplantation/*economics
Heterocyclic Compounds/*economics
Multiple Myeloma/*economics
Adult ; Aged ; Autografts ; Benzylamines ; Costs and Cost Analysis ; Cyclams ; Female ; Granulocyte Colony-Stimulating Factor/administration & dosage ; Hematopoietic Stem Cell Mobilization/methods ; Heterocyclic Compounds/administration & dosage ; Humans ; Lebanon ; Male ; Middle Aged ; Multiple Myeloma/therapy ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Impact of length of cryopreservation and origin of cord blood units on hematologic recovery following cord blood transplantation.
Autorzy:
Kurita N; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Frassoni F; The Stem Cell and Cell Therapy Lab, Istituto G. Gaslini, Genoa, Italy.
Chiba S; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Podestà M; The Stem Cell and Cell Therapy Lab, Istituto G. Gaslini, Genoa, Italy.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Jun; Vol. 50 (6), pp. 818-21. Date of Electronic Publication: 2015 Mar 23.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Blood Preservation*
Cord Blood Stem Cell Transplantation*
Cryopreservation*
Multiple Myeloma*/immunology
Multiple Myeloma*/therapy
Fetal Blood/*immunology
Hematopoiesis/*immunology
Recovery of Function/*immunology
Adult ; Aged ; Female ; Graft vs Tumor Effect/immunology ; Humans ; Male ; Middle Aged ; Myeloid Cells/immunology ; Retrospective Studies ; T-Lymphocytes, Regulatory/immunology ; Time Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT.
Autorzy:
Grövdal M; Department of Medicine, Karolinska Institutet, Center for Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Nahi H; Department of Medicine, Karolinska Institutet, Center for Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Gahrton G; Department of Medicine, Karolinska Institutet, Center for Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Liwing J; Department of Medicine, Karolinska Institutet, Center for Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Waage A; 1] Saint Olavs Hospital, Norwegian University of Science and Technology, Trondheim, Norway [2] KG Jebsen Center for Myeloma Research, IKM, Norwegian University of Science and Technology, Trondheim, Norway.
Abildgaard N; Department of Hematology, Odense University Hospital, Odense, Denmark.
Pedersen PT; Department of Hematology, Esbjerg Hospital, Esbjerg, Denmark.
Hammerstrøm J; 1] Saint Olavs Hospital, Norwegian University of Science and Technology, Trondheim, Norway [2] KG Jebsen Center for Myeloma Research, IKM, Norwegian University of Science and Technology, Trondheim, Norway.
Laaksonen A; Department of Hematology, Turku University Hospital, Turku University, Turku, Finland.
Bazia P; Department of Hematology, Kainuu Central Hospital, Kajaani, Finland.
Terava V; Department of Hematology, Tampere University Hospital, Tampere, Finland.
Ollikainen H; Department of Hematology, Satakunta Central Hospital, Pori, Finland.
Silvennoinen R; Department of Hematology, Kuopio University Hospital, Kuopio, Finland.
Putkonen M; Department of Hematology, Turku University Hospital, Turku University, Turku, Finland.
Anttila P; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Porkka K; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Remes K; Department of Hematology, Turku University Hospital, Turku University, Turku, Finland.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Jun; Vol. 50 (6), pp. 808-12. Date of Electronic Publication: 2015 Apr 13.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article; Multicenter Study
MeSH Terms:
Stem Cell Transplantation*
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Multiple Myeloma/*therapy
Adult ; Aged ; Autografts ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma.
Autorzy:
Lendvai N; 1] Myeloma Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA.
Cohen AD; Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Cho HJ; Multiple Myeloma Service, Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Jun; Vol. 50 (6), pp. 770-80. Date of Electronic Publication: 2015 Mar 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Stem Cell Transplantation*
Cancer Vaccines/*immunology
Cancer Vaccines/*therapeutic use
Graft vs Tumor Effect/*immunology
Multiple Myeloma/*immunology
Multiple Myeloma/*therapy
Autografts ; Clinical Trials as Topic ; Disease-Free Survival ; Humans ; Multiple Myeloma/mortality ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Immortal person-time bias in the association between herpes zoster and survival following autologous stem cell transplantation.
Autorzy:
Schmidt SA; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Lash TL; 1] Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark [2] Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Jun; Vol. 50 (6), pp. 878-9. Date of Electronic Publication: 2015 Mar 30.
Typ publikacji:
Letter; Comment
MeSH Terms:
Herpes Zoster*
Multiple Myeloma*
Stem Cell Transplantation*
Virus Activation*
Antibodies, Viral/*blood
Herpesvirus 3, Human/*physiology
Female ; Humans ; Male
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Utilization of stored autologous PBSCs to support second autologous transplantation in multiple myeloma patients in the era of novel agent therapy.
Autorzy:
Phipps C; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Department of Haematology, Singapore General Hospital, Singapore, Singapore.
Linenberger M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Holmberg LA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Green D; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Becker P; Department of Medicine, University of Washington, Seattle, WA, USA.
Connelly-Smith L; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Klippel Z; Amgen Inc., Thousand Oaks, CA, USA.
Burwick N; Medical Oncology, University of Washington, Seattle, WA, USA.
Gopal A; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Medical Oncology, University of Washington, Seattle, WA, USA.
Bensinger WI; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Libby E; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 May; Vol. 50 (5), pp. 663-7. Date of Electronic Publication: 2015 Mar 02.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Component Removal*/economics
Blood Component Removal*/methods
Cryopreservation*/economics
Cryopreservation*/methods
Multiple Myeloma*/economics
Multiple Myeloma*/therapy
Peripheral Blood Stem Cell Transplantation*/economics
Peripheral Blood Stem Cell Transplantation*/methods
Adult ; Aged ; Autografts ; Costs and Cost Analysis ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation.
Autorzy:
Brioli A; Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Perrone G; Hematology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Patriarca F; Department of Hematology, Stem Cell Transplant Unit, DISM, University Hospital, Udine, Italy.
Pezzi A; Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Nobile F; Hematology Unit, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy.
Ballerini F; Department of Hematology and Oncology, IRCCS AOU San Martino-IST, Genova, Italy.
Motta MR; Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Ronconi S; Department of Hematology, Istituto Scientifico Romagnolo per Studio e Cura dei Tumori, Meldola, Italy.
Tacchetti P; Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Catalano L; Divisione di Ematologia, Università Federico II, Napoli, Italy.
Zannetti BA; Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Rizzi S; Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Volpe S; Division of Onco-Hematology, S.G. Moscati Hospital, Avellino, Italy.
Zamagni E; Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Liberati AM; Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Perugia, Struttura Complessa Oncoematologia con autotrapianto, Azienda Ospedaliera Santa Maria, Terni, Italy.
Mancuso K; Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Boccadoro M; Division of Hematology, University of Torino, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy.
Davies FE; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Morgan GJ; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Palumbo A; Division of Hematology, University of Torino, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy.
Cavo M; Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 May; Vol. 50 (5), pp. 673-8. Date of Electronic Publication: 2015 Feb 02.
Typ publikacji:
Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Peripheral Blood Stem Cell Transplantation*
Bortezomib/*administration & dosage
Dexamethasone/*administration & dosage
Hematopoietic Stem Cell Mobilization/*methods
Multiple Myeloma/*therapy
Thalidomide/*administration & dosage
Autografts ; Female ; Humans ; Induction Chemotherapy/methods ; Male ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Allogeneic hematopoietic SCT in multiple myeloma: long-term results from a single institution.
Autorzy:
Rosiñol L; 1] Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain [2] Bone Marrow Transplant Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain [3] Amyloid and Myeloma Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain.
Jiménez R; 1] Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain [2] Amyloid and Myeloma Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain.
Rovira M; 1] Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain [2] Bone Marrow Transplant Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain.
Martínez C; 1] Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain [2] Bone Marrow Transplant Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain.
Fernández-Avilés F; 1] Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain [2] Bone Marrow Transplant Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain.
Marín P; 1] Bone Marrow Transplant Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain [2] Hemostherapy and Hemostasis Department, Hospital Clínic, IDIBAPS, Barcelona, Spain.
Suárez-Lledó M; 1] Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain [2] Bone Marrow Transplant Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain.
Gutiérrez-García G; 1] Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain [2] Bone Marrow Transplant Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain.
Fernández de Larrea C; 1] Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain [2] Amyloid and Myeloma Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain.
Carreras E; 1] Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain [2] Bone Marrow Transplant Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain.
Urbano-Ispizua A; 1] Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain [2] Bone Marrow Transplant Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain [3] Institut of Research Josep Carreras, Barcelona, Spain.
Bladé J; 1] Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain [2] Amyloid and Myeloma Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 May; Vol. 50 (5), pp. 658-62. Date of Electronic Publication: 2015 Jan 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Transplantation Conditioning*
Graft vs Host Disease/*mortality
Graft vs Host Disease/*therapy
Multiple Myeloma/*mortality
Multiple Myeloma/*therapy
Acute Disease ; Adult ; Aged ; Allografts ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial.
Autorzy:
Iacobelli S; Centro Interdipartimentale di Biostatistica e Bioinformatica, Università di Roma 'Tor Vergata', Rome, Italy.
de Wreede LC; Department of Biostatistics and Bioinformatic, Leiden University Medical Center, Leiden, The Netherlands.
Schönland S; Department of Medicine V, University Hospital of Heidelberg, Heidelberg, Germany.
Björkstrand B; Hematology Center/Huddinge, Karolinska University Hospital, Stockholm, Sweden.
Hegenbart U; Department of Medicine V, University Hospital of Heidelberg, Heidelberg, Germany.
Gruber A; Department of Medicine, Karolinska Institute at Huddinge and Solna, Stockholm, Sweden.
Greinix H; Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
Volin L; Helsinki University Central Hospital, Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki, Finland.
Narni F; Department of Oncology Hematology & Respiratory Diseases, AOU Policlinico Modena, University of Modena, Modena, Italy.
Carella AM; Department of Hematology and Stem Cell Transplant Unit, CSS Hospital IRCCS, S.G. Rotondo, Italy.
Beksac M; Department of Hematology, Ankara University Faculty of Medicine, Ankara, Turkey.
Bosi A; Department of Haematology, University of Florence, Careggi Hospital, Florence, Italy.
Milone G; Department of Haematology, Ospedale Ferrarotto, Catania, Italy.
Corradini P; Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy.
Friberg K; Department of Medicine, Karolinska Institute at Huddinge and Solna, Stockholm, Sweden.
van Biezen A; Department of Biostatistics and Bioinformatic, Leiden University Medical Center, Leiden, The Netherlands.
Goldschmidt H; Department of Medicine V, University Hospital of Heidelberg, Heidelberg, Germany.
de Witte T; Department of Tumor Immunology, Nijmegen Institute of Life Sciences, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Morris C; Department of Haematology, The Queens University, Belfast, UK.
Niederwieser D; Division of Hematology and Medical Oncology, University Hospital Leipzig, Leipzig, Germany.
Garderet L; Département d'hématologie et de thérapie cellulaire, Hopital St Antoine, Paris, France.
Kröger N; Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Gahrton G; Department of Medicine, Karolinska Institute at Huddinge and Solna, Stockholm, Sweden.
Pokaż więcej
Corporate Authors:
EBMT CMWP, Plasma Cell Disorders Subcommittee
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Apr; Vol. 50 (4), pp. 505-10. Date of Electronic Publication: 2015 Jan 26.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Stem Cell Transplantation*
Multiple Myeloma/*mortality
Multiple Myeloma/*therapy
Allografts ; Autografts ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Remission Induction ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Inadvertent transmission of occult CML through allo-SCT.
Autorzy:
de Brito MD; Bone Marrow Transplantation Service, Portuguese Institute of Oncology, Porto, Portugal.
Campilho F; Bone Marrow Transplantation Service, Portuguese Institute of Oncology, Porto, Portugal.
Branca R; Bone Marrow Transplantation Service, Portuguese Institute of Oncology, Porto, Portugal.
Vaz CP; Bone Marrow Transplantation Service, Portuguese Institute of Oncology, Porto, Portugal.
Campos A; Bone Marrow Transplantation Service, Portuguese Institute of Oncology, Porto, Portugal.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Apr; Vol. 50 (4), pp. 598. Date of Electronic Publication: 2015 Jan 12.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Stem Cell Transplantation*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*etiology
Multiple Myeloma/*therapy
Allografts ; Female ; Humans ; Male ; Middle Aged
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myeloma.
Autorzy:
Giaccone L; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza and Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
Brunello L; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza and Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
Festuccia M; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza and Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
Gilestro M; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza and Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
Maffini E; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza and Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
Ferrando F; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza and Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
Talamo E; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza and Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
Passera R; Division of Nuclear Medicine, Azienda Ospedaliera Universitaria Città della Salute e della Scienza and University of Torino, Torino, Italy.
Boccadoro M; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza and Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
Omedè P; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza and Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
Bruno B; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza and Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Apr; Vol. 50 (4), pp. 511-6. Date of Electronic Publication: 2015 Feb 09.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma/*mortality
Multiple Myeloma/*therapy
Adult ; Aged ; Allografts ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Remission Induction ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 368

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies